Account
Pulp Strategy wins digital mandate for Jagatjit Industries
Mumbai: Producer of IMFL brands in India, Jagajit Industries Ltd (JIL) has awarded its digital mandate to independent digital agency Pulp Strategy. JIL is an integrated distillery manufacturing potable alcohol in Asia, with in-house facilities for producing molasses and non-molasses-based potable alcohol from fully-automated distillation plants.
Pulp Strategy’s mandate includes digital and marketing intervention across JIL brands, the agency will also be responsible for digital strategy and content marketing for JIL, said the statement.
“Pulp Strategy, demonstrated a good understanding of our industry and our brand ethos, including our focus on creativity and out-of-the-box thinking, and corporate responsibility,” stated JIL head of marketing Neha Gupta. “They were able to translate insights into a holistic solution-based approach for our brands…. We are looking forward to working in tandem to attain our goals.”
Commenting on the acquisition, Pulp Strategy managing director Ambika Sharma added, “The team at JIL is extremely passionate about their legacy, and have a transformative vision for growth, they have strong brands, and we are looking forward to working with the team to build a strong value-driven digital marketing practice.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
